Physician

Nathan Boone Richards, M.D.

According to 2025 Medicare claims, Nathan Richards, M.D. (NPI: 1497968366) practices allergy/immunology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Clark, IN. This provider's primary affiliated billing organization is PSF PLLC (NPI: 1881785947; TIN: 611389493) and primary practice location at 47150-8302.

Richards' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 475 traditional Medicare patients, billed 27,043 HCPCS/CPT codes, and received $351,698 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,976 prescription claims across 386 beneficiaries totaling $766,790 in drug costs, led by Dupixent Pen (Dupilumab). DME data shows 17 claims. Open Payments data shows 53 records totaling $1,022. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $75,101 to $351,698. Similarly, Part D prescription costs have moved sharply higher in recent years, from $145,327 to $766,790. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $496 to $476.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	335	8,972	$75,101
2016	383	8,880	$81,632
2017	419	9,814	$116,764
2018	563	12,755	$117,614
2019	814	17,602	$167,159
2020	816	15,416	$194,486
2021	778	16,130	$219,417
2022	662	17,086	$254,463
2023	465	20,403	$268,423
2024	475	27,043	$351,698

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	152	1,145	$145,327
2016	197	1,250	$159,242
2017	225	1,413	$173,191
2018	270	1,608	$302,166
2019	288	1,746	$356,213
2020	261	1,671	$327,582
2021	254	1,419	$260,043
2022	257	1,363	$334,368
2023	317	1,711	$734,437
2024	386	1,976	$766,790

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$85
2016	N/R	36	$400
2017	N/R	88	$27,948
2018	N/R	37	$28,874
2019	N/R	39	$30,001
2020	N/R	57	$42,422
2021	N/R	N/R	N/R
2022	N/R	12	$102
2023	N/R	N/R	N/R
2024	N/R	17	$362

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	230	296	$61
94375	Test to measure rate of airflow	132	168	$27
95012	Test to measure the level of nitric oxide gas	123	154	$13
95165	Professional service for preparation and provision of 1 or more antigens	256	6,920	$9
95117	Professional service for multiple injections of allergen	307	5,587	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	40	1,120	$146,651
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	82	3,300	$69,141
Nucala	Mepolizumab	13	364	$45,078
Spiriva Respimat	Tiotropium Bromide	52	1,910	$32,970
Breo Ellipta	Fluticasone/Vilanterol	67	2,580	$32,715

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	17	$362

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	53	$1,022	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nathan Boone Richards, M.D.?

Tedicare shows public-source Medicare data for Nathan Boone Richards, M.D. (NPI 1497968366), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nathan Boone Richards, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nathan Boone Richards, M.D.?

Nathan Boone Richards, M.D. is linked to PSF PLLC (billing NPI 1881785947) in the available physician profile data.

Does Nathan Boone Richards, M.D. have Open Payments data?

Nathan Boone Richards, M.D. has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.